Incannex Healthcare Inc. (IXHL:NASDAQ) closed at $2.49 on November 4, 2026, unchanged on the day. The stock trades 83.3% below its 52-week high of $14.91 and 14.7% above its 52-week low of $2.17. Over the past year, it lost 77.2%. Incannex Healthcare Inc. is part of the Health Care sector.
In 252 trading sessions since November 4, 2025, IXHL closed higher on 111 days (44%). Its best day was March 11, 2026 (+19.16%) and its worst was March 12, 2026 (-48.41%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 2 times.
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
Find more stocks like IXHL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.